Abstract
The invention features combination therapies using an IL-15-based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases.
Full Text
What is claimed is:
The invention features combination therapies using an IL-15-based superagonist complex and an antibody to effectively treat subjects with cancer and infectious diseases.
Timeline
Filed
05/08/2026Published
09/03/2026Granted
Not AvailableIPC Codes(10)
A61K 38/20:Interleukins
A61K 38/17:from animals; from humans
A61K 39/04:Mycobacterium, e.g. Mycobacterium tuberculosis